Pamela joined UCL Translational Research Office (TRO) in 2014 and has been leading the Translational Research group since 2016.    The TRO collaborates with academics, industry partners and external funding bodies, to facilitate the translation of UCL’s emerging research into therapies and medical products.   Pamela is the project manager for several substantial late pre-clinical/early clinical translational projects in biologics and cell and gene therapy, including industry funded/partnered projects.  The Translational Research Group currently supports more than 45 active projects with a value of greater than £85 Million. 

Pamela is leading a key initiative to develop Therapeutic Innovation Networks (TINs) for all therapeutic modalities across UCL, which is supported by a WT Translational Partnership Award. 

Prior to joining UCL, Pamela gained extensive experience of drug discovery in the pharmaceutical industry at Novartis/Ciba-Geigy where she led projects small molecule and biologics targets for respiratory and thrombosis indications.